|
The National
Resource Center for Primary Care Practice Based Research Networks. Funding was received from the Agency for Healthcare
Research and Quality (AHRQ) to operate and manage the National
Practice Based Research Network (PBRN) Resource Center. The Resource
Center serves as the major Federal source of infrastructure support
to primary care PBRNs, especially new and emerging networks. It
provides resources and assistance to primary care PBRNs engaged in
clinical and health services research. The staff provides support to
registered PBRNs through a series of web-based seminars and the
provision of technical research expertise. The PBRN resource center
also helps plan and manage the annual AHRQ PBRN Research Conference
held in May.
Developing a
Distributed Research Network and Cooperative to Conduct
Population-based Studies and Safety Surveillance.
This subcontract was awarded by the Agency for Healthcare Research
and Quality (AHRQ). The Distributed Ambulatory Research in
Therapeutics Network (DARTNet) is a prototype federated network of
electronic health record (EHR) data from eight organizations
representing over 200 clinicians and over 350,000 patients. The
prototype system will capture, codify and standardize over 200
unique data elements per patient for up to 24 months of time. It
will explore how currently available EHR data can be used to
supplement data from large administrative datasets in order to
answer questions concerning the safety and effectiveness of
medications and medical devices. Furthermore, the expertise of the
participating PBRNs will be used to explore the ability to fill gaps
in clinical data using point of care data collection techniques.
The Minnesota
Academy of Family Physicians Research Network (MAFPRN).
The MAFPRN was recently awarded a task order contract by the DHHS
Agency for Healthcare Research and Quality (AHRQ) for Primary
Care-Practice Based Research Networks (PBRNs). All work required
under this contract will be performed through the issuance of task
orders. Competitive (or justified sole source) requests for task
orders (RFTOs) will be sent throughout the fiscal year. Each
contractor will be guaranteed at least one task order over the
course of the contract.
In addition to these new studies, there are several ongoing studies.
Atherothrombosis
Intervention in Metabolic Syndrome.
Funding for this project was awarded by the National Institutes of
Health (NHLBI) through subcontract with the Axio Research. As a
clinical center for the AIM-HIGH Trial, testing will be done to
determine whether the combination of niacin and simvastatin lowers
the risk of heart attacks and strokes more than just taking
simvastatin alone. The scope of work includes recruitment and
informed consent of approximately 55 eligible subjects, collection
of the required baseline data, post-randomization clinical events
and fasting laboratory values according to the prescribe visit
schedule. All required data collection will be entered on the
study’s secure website.
Cancer Central
Clinical Database (C3D) Trial.
The ePCRN was awarded a contract from the caBIG, an initiative of
the National Cancer Institute, NIH, DHHS to conduct two clinical
trials using the C3D. The C3D is a web-based clinical data
management solution originally developed for NCI’s intramural
research program but is now available to other research
organizations in a hosted Application Service Provider model. C3D
supports data standardization, reuse, sharing, and interoperability
through electronic Case Report Forms based on Common Data Elements
maintained in NCICB’s Cancer Data Standards Repository and
controlled by terminology from the NCI Enterprise Vocabulary
Services. We are currently in the process of identifying possible
cancer trials to conduct.
The electronic
Primary Care Research Network (ePCRN).
This project,
funded by an NIH award to a collaboration of the Federation of
Practice-based Research Networks (FPBRN), the MAFPRN, and the
University of Minnesota, makes it possible for PBRNs to participate
in large randomized controlled trials. The ePCRN is designed to
support primary care providers in conducting clinical research in
their practices and to provide secure, cutting-edge technology along
with training, support and technical assistance. This technology
enables practices to create disease registries and report quality
indicators, and to better communicate and coordinate activities
among practices. Sophisticated videoconferencing is also supported
by the ePCRN.
AccessGrid.
Internet video conferencing has become a crucial resource for
supporting the development activities of the electronic Primary Care
Research Network. The ePCRN has successfully adopted the AccessGrid
Toolkit, an open-source, community developed software package
managed by the Argonne National Laboratory. The high quality visual
and audio performance produced by the AccessGrid is unlike
teleconferencing most people have experienced. By using the
AccessGrid, ePCRN directors located across the nation meet monthly
as though they are in the same room. Also, weekly ePRCN systems and
software development meetings take place among team members located
in San Francisco, Minneapolis, and Birmingham, England. Since each
site presents visual and audio content to other sites simultaneously
all participants can equally interject during discussions and gauge
reactions simply by sight. Efforts by the ePCRN are underway to
make this technology available to most primary care physicians in
the clinical settings. Possibilities exist for clinician training
and clinician-patient interaction remotely. Recent breakthroughs
hold great promise toward achieving these goals.
ACCORD.
Phalen Village Clinic is one of the few Family Medicine
Clinics participating in the NIH sponsored ACCORD Study. The
findings of ACCORD are producing national changes in health care
quality measures. ACCORD is an acronym for Action to Control
Cardiovascular Risk in Diabetes. This study completed the
recruitment phase in October, 2005
enrolling 10,251 patients at 70 sites in the US and Canada. Phalen
Village Clinic has 184 participants enrolled. The study will be
completed in 2009. The aim is to test whether intensive control of
blood glucose (A1c less than 6) is more effective in reducing
cardiovascular events than conventional control. The separate
effects of two levels of blood pressure and two methods of lipid
control are being tested as well. Sub-studies looking at the effect
of blood glucose control, lipid management and blood pressure
control on bone density, vision and memory are underway also. The
National Heart, Lung, and Blood Institute (NHLBI), which sponsors
the ACCORD trial, recently stopped the intensive blood sugar
lowering treatment in the study and is transitioning participants in
that treatment group to the same goal as participants in the
standard treatment group. NHLBI decided to change this treatment due
to safety concerns after a thorough review of the available data and
a recommendation by the study's Data and Safety Monitoring Board.
The other two treatment questions being examined in the study--the
blood pressure and lipid trials--will continue until June 2009 as
planned. Therefore, ACCORD participants will continue to receive
blood sugar treatment from their study clinicians until the planned
trial conclusion in June 2009. |